Overview
Takayoshi Umeda practices practicing medicine in Hongo, Japan.
Their clinical expertise encompasses Ependymoma, Glioma, Gliomatosis Cerebri, and Spinal Tumor.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takayoshi Umeda
Is Takayoshi Umeda a top-rated expert for Ependymoma?
MediFind is an objective health platform that identifies experts based on real-world data. Takayoshi Umeda is classified as an Experienced expert for Ependymoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takayoshi Umeda participate in research or clinical trials?
Yes. Takayoshi Umeda has published 10 articles and abstracts on conditions like Ependymoma. You can view a list of Takayoshi Umeda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EpendymomaUmeda isExperienced. Learn about Ependymoma.
- GliomaUmeda isExperienced. Learn about Glioma.
- Gliomatosis CerebriUmeda isExperienced. Learn about Gliomatosis Cerebri.
- HepatoblastomaUmeda isExperienced. Learn about Hepatoblastoma.
- Spinal TumorUmeda isExperienced. Learn about Spinal Tumor.